Projects per year
- 1 - 50 out of 120 results
Search results
-
ADAPT SEPSIS - Biomarker-guided duration of antibiotic treatment in hospitalised patients with moderate or severe sepsis
1/05/17 → 31/07/24
Project: Other Government Departments
-
Adjuvant Chemotherapy with Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Cholangiocarcinoma (ACTICCA-1 Trial)
Fox, R., Ma, Y. T. & Stubbs, C.
1/04/15 → 30/11/24
Project: Research
-
AGCT1531: A Phase 3 Study of Active Surveillance for Low Risk and a Randomised Trial of Carboplatin vs. Cisplatin for Standard Risk Paediatric and Adult Patiants with Germ Cell Tumours
Kearns, P., Fenwick, N. & Gough, R.
1/06/18 → 30/11/26
Project: Research
-
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Rowe, A., Slade, D., Gates, S., Curbishley, S. & Homer, V.
1/11/21 → 31/01/28
Project: Research Councils
-
AMADEUS - Double-blind,IMPACT phase III,Randomised Study to Compare the Efficacy and Safety to Oral AZA(CC-486)Versus Placebo in Subject with Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance after Allogeneic Haematopoietic
Craddock, C., Siddique, S. & Jackson, A.
1/04/18 → 31/03/28
Project: Industry
-
A Phase 2a trial of Avelumab, an anti-PDL 1 antibody, in relapsed and refractory peripheral T-cell lymphoma (AVAIL-T)
Siddique, S., Jackson, A. & Craddock, C.
6/07/17 → 31/12/24
Project: Industry
-
A phase II trial of MK-3475 in patients with non-small cell lung cancer with a performance status of 2 (PePS2)
Billingham, L. & Middleton, G.
21/10/15 → 31/12/24
Project: Industry
-
A phase II trial to assess the activity of Gemtuzumab Ozogamicin Therapy in HAemophagocytic lymphohistiocytosis (HLH) or Macrophage activation syndrome (MAS) or relapsed/refractory solid tumours
De Santo, C., Kearns, P., Billingham, L., Middleton, G. & Mussai, F.
Little Princess Trust, Eveson Charitable Trust
1/01/20 → 31/12/24
Project: Research
-
A randomised phase 2 study of ASTX727 versus best supportive care in MDS/MPN Overlap Syndromes
Fox, S., Boucher, B., Craddock, C. & Jackson, A.
1/03/21 → 31/08/25
Project: Research
-
A Randomised Phase IIb Trial of BEvACizumab Added to Temozolomide + IrinOtecan for Children with Refractory/Relapsed Neuroblastoma - BEACON Trial
EUSA Pharma (UK) Limited, SOLVING KIDS' CANCER, Cancer Research Uk, INNOVATIVE THERAPIES FOR CHILDREN WITH CANCER (ITCC)
1/01/13 → 30/11/24
Project: Research
-
A randomised phase II study of temozolomide with or without cannabinoids in patients with recurrent glioblastoma: ARISTOCRAT
Patel, A., Billingham, L. & Savage, J.
1/02/23 → 28/02/25
Project: Research
-
Assessment of the Mechanism of Action of Venetoclax (ABT-199) in combination with Ibrutinib (PCI-32765) in relapsed/refractory Chronic Lymphocytic Leukaemia (CLARITY)
Brock, K. & Siddique, S.
Janssen-Cilag Limited, BLOODWISE, Abbvie Ltd
1/01/16 → 31/05/24
Project: Research
-
ASTIC-LITE:Autologous Stem Cell Transplantation in refractory Crohn’s disease – Low Intensity Therapy Evaluation
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/08/18 → 31/03/27
Project: Other Government Departments
-
ATRT01 (full): An international prospective umbrella trial for children with ATRT
1/07/22 → 31/03/31
Project: Research
-
Axi-STS: A Clinicopathological phase II study of axitinib in patients with advanced angiosarcoma and other soft tissue sarcomas.
Billingham, L. & Hughes, A.
Cancer Research Uk, PFIZER LIMITED
1/06/10 → 31/12/25
Project: Research
-
BEACON2 - A multi-arm multi-stage platform trial for relapsed and refractory neuroblastoma
Gates, S., Kearns, P., Firth, C. & Laidler, J.
1/07/23 → 30/06/26
Project: Research
-
Biomede 2.0: Full: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
1/07/23 → 30/06/33
Project: Research
-
BRAIN-MATRIX:A British feasibility study of molecular stratification and targeted therapy to optimize the clinical mAnagement of patleNts with glioMA by enhancing clinical ouTcomes, Reducing avoldable toXicity, improving management of post-
Fox, R., Watts, C. & Stubbs, C.
THE BRAIN TUMOUR CHARITY, GENOMICS ENGLAND LTD
1/03/19 → 28/02/27
Project: Research
-
Cancer Research UK Birmingham Centre. See Also RCPV20624
Kearns, P., Willcox, B., Lee, S., Middleton, G., Moss, P. & Morton, D.
1/04/17 → 31/12/24
Project: Research
-
Centre for Conflict Wound Research
Logan, A., Lord, J., Williams, R., Harrison, P., Barton, D. & Grover, L.
1/09/18 → 31/08/25
Project: Research
-
Changing clinical practice in rare diseases through innovative trial designs: the CAPTIVATE node
Barrett, T., Homer, V., Gates, S., Kearns, P. & Billingham, L.
3/07/23 → 2/07/28
Project: Research Councils
-
Clinical training Award - Cycle 4 - 2018
Kearns, P., Taylor, G. & Gough, R.
1/09/18 → 31/05/24
Project: Research
-
COSI: An international randomised clinical trial of therapeutic interventions with the potential to improve outcome in adults with acute myeloid leukaemia and high risk myelodysplasia undergoing allogeneic stem cell transplantation
Craddock, C. & Jackson, A.
Jazz Pharmaceuticals, ADIENNE s.r.l
1/09/19 → 31/12/26
Project: Industry
-
COVID19 BMT: A prospective non interventional study to evaluate the role of immune and inflammatory response in recipients of allogeneic haematopoietic stem cell transplantation (SCT) affected by severe COVID19 infection
Bishop, R., Craddock, C. & Jackson, A.
1/08/20 → 31/12/25
Project: Industry
-
CRISP: A phase Ib of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies (Study ITCC 053)
Fenwick, N., Kearns, P. & Seaford, E.
Cancer Research Uk, Erasmus Univesitair Medisch Centrum
1/04/18 → 31/10/24
Project: Research
-
CRUK/13/026: CompARE: Phase III randomised controlled trial Comparing Alternative Regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer
Gaunt, P., Billingham, L., Mehanna, H. & Bowden, S.
Cancer Research Uk, ASTRA ZENECA UK LIMITED, CITY HOSPITAL NHS TRUST
1/11/14 → 31/12/25
Project: Research
-
CRUK/17/011 FaR-RMS: A multiarm-multistage study for children and adults with localised and metastatic frontline and relapsed RhabdoMyoSarcoma.
Kearns, P., Gatz, S., Liu, W., Gaunt, P., Jackson, A. & Pirrie, S.
Cancer Research Uk, SIOP Europe
1/02/18 → 31/01/28
Project: Research
-
CRUK/17/013 E-smart : European proof of concept therapeutic stratification trial of molecular anomalies in replapsed or refractory tumours in children(E-smart)
Kearns, P., Fenwick, N. & Gough, R.
1/11/17 → 28/02/25
Project: Research
-
CRUK CRCTU Core Funding
Fisher, B., Billingham, L., Bach, S., Kearns, P., Pratt, G., Bowden, S., Rea, D., Middleton, G. & Gates, S.
1/10/23 → 30/09/28
Project: Research
-
Development of a novel repurposed drug treatment for neurodegeneration and diabetes in Wolfram syndrome
Nagy, Z., Peet, A., Brock, K., Barrett, T. & Martin, U.
1/03/17 → 28/02/25
Project: Research Councils
-
EME -A Phase II Randomised Clinical Trial of Conditioning Cyclophosphamide and Chemoembiolisation with or without Vaccination with Dendritic Cells Pulsed with HepG2 Lysate in vivo in Patients with Hepatocellular Carcinoma : IMMUNOTACE Trial
Barton, D., Steven, N., Adams, D. & Gough, R.
1/01/13 → 31/12/25
Project: Other Government Departments
-
FAecal microbiota transplantation in primaRy sclerosinG chOlangitis: The FARGO trial
Trivedi, P., Beggs, A. & Gates, S.
1/03/22 → 28/02/26
Project: Research
-
FaR-RMS - An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma
Bowden, S., Kearns, P., Gatz, S., Pirrie, S., Jackson, A., Liu, W. & Gaunt, P.
1/01/21 → 30/06/31
Project: EU
-
FEDORA: A phase II study to evaluate the safety, toxicity and tolerability of the combination of fedratinib and ropeginterferon alfa-2b, in patients with myelofibrosis
Fox, S., Craddock, C. & Jackson, A.
AOP Orphan Pharmaceuticals GmbH
31/12/21 → 30/06/26
Project: Research
-
FEDORA - A phase II study to evaluate the tolerability, safety and activity of fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis
Jackson, A., Fox, S. & Craddock, C.
3/12/21 → 30/06/26
Project: Industry
-
Fluid-Gels as Resorbable Protective Dressings for Ocular Surface Disease
Slade, A., Rauz, S. & Slade, A.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/03/19 → 30/09/24
Project: Other Government Departments
-
Global Study of Novel Agents in relapsed and refractory B-NHL with ADCT
Billingham, L., Kearns, P., Siddique, S. & Holt, G.
1/08/21 → 31/01/28
Project: Industry
-
Glo-BNHL: ADCT Collaboration: A Global Study of Novel Agents in Relapsed and Refractory B-Non Hodgkin Lymphoma
Bishop, R., Maycock, S., Kearns, P. & Billingham, L.
1/07/23 → 30/06/27
Project: Industry
-
Glo-BNHL: BMS Collaboration: A Global Study of Novel Agents in Relapsed and Refractory B-Non Hodgkin Lymphoma
Billingham, L., Bishop, R., Burke, A., Lawson, A. & Maycock, S.
BRISTOL MYERS SQUIBB PHARMACEUTICALS
1/05/24 → 30/04/29
Project: Industry